Immuno Oncology Assays Market: Emerging Business Trends and Opportunities
This study
involved four major activities in estimating the current size of the immuno-oncology assays market. Exhaustive secondary research was carried out to collect
information on the market, its peer markets, and its parent market. The next
step was to validate these findings, assumptions, and sizing with industry
experts across the value chain through primary research. Both top-down and
bottom-up...
Immuno Oncology Assays Market – Latest Trends and Future Forecast
The major
players in immuno-oncology assays market are Thermo Fisher Scientific,
Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc.
(US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG
(Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck
Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US),
Guardant Health,...
How Increased Demand for Personalized Medicine Impacting Immuno Oncology Assays Market
What This Report
Will Provide?
This study involved four major
activities in estimating the current size of the interventional oncology
market. Exhaustive secondary research was carried out to collect information on
the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with
industry experts across the value chain through primary...
Immuno Oncology Assays Market | Emerging Technologies Accelerating Business in Healthcare Industry
What the Immuno
Oncology Assays Market looks like?
Growth in Immuno Oncology Assays Market is largely driven by factors
such as the increasing adoption of targeted therapy over traditional therapy
and the increasing demand for mAbs.
According to the new market research report “Immuno Oncology
Assays Market by Product (Consumables, Software), Technology (Immunoassay,
Flow Cytometry,...
Immuno Oncology Assays | An Emerging Market Growing at a CAGR of 12.7%
The
global immuno oncology assays market
to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7%
during the forecast period. The rising
incidence of cancer and increasing adoption of targeted therapy are
the key factors driving the market. Companion diagnostics have been identified as an area of opportunity for
companies seeking to develop innovative products or capabilities...
Immuno Oncology Assays Market Emerging and Latest Trends 2019
The global immuno-oncology assays market to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The rising incidence of cancer and increasing adoption of targeted therapy are the key factors driving the market. Companion diagnostics have been identified as an area of opportunity for companies seeking to develop innovative products or capabilities...